The interview says it all , phase1/2a trials two thirds complete on cancer , POSITIVE REACTION AGAINST THE CANCERS ALREADY SEEN AT TINY DOSAGES , way earlier than they expected , no bad side effects ever seen , psoraisis trials , no partnership deals to be considered till some solid data to maximise returns to shareholders etc , etc . http://www.wallstreetreporter.com/linked/SolbecPharmaceuticals.html
SBP Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.